Rapidly growing interest in using nanoparticles (NPs) for biomedical applications has
increased concerns about their safety and toxicity. In comparison with bulk materials, NPs …

Nanocarriers have been widely employed in preclinical studies and clinical trials for the
delivery of anticancer drugs. The most important causes of failure in clinical translation of …

Codelivery of chemotherapeutics via nanomaterials has attracted much attention over the
last decades due to improved drug delivery to tumor tissues, decreased systemic effects …

Carboplatin (CRBP) is a chemotherapeutic agent based on platinum that has applications in
the effective management of ovarian, testis, cervical, neck, head, and small cell lung cancer …

Targeted drug delivery systems (TDDS) are currently considered to overcome traditional
drug delivery systems' criticisms and weaknesses. Biodegradable hydrogels are widely …

Carbon quantum dots (CQDs) are a new carbon-based nanomaterial that has attracted
tremendous attention due to their excellent fluorescent properties, chemical stability, water …

Cancer treatments, including traditional chemotherapy, have failed to cure human
malignancies. The main reasons for the failure of these treatments are the inevitable drug …

Ovarian cancer has the highest mortality rate among gynecological cancers. It requires
urgent therapy, but standard treatments are not sufficient to cure ovarian cancer completely …

Polymeric microspheres (MSs) and nanospheres (NSs) composed of synthetic and natural
polymers can encapsulate anticancer drugs, among other therapeutics, acting as drug …

In this study, a nano-drug delivery design based on (8, 8) carboxylated single-walled carbon
nanotube (CNT-COOH) and folic acid (FA) decorated on CNT-COOH (CNT-FA) were …